AbCellera Biologics Inc. (ABCL) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript

Group 1 - The company, AbCellera, is at an exciting phase in its history, leveraging a strong technological advantage in antibody discovery from natural immune systems [2][3] - AbCellera has developed a platform over the last decade that focuses on identifying antibodies that can serve as effective therapeutics [2] - The company is currently engaged in both partnered and pre-partnered programs, indicating a diverse pipeline of opportunities [1]